Literature DB >> 26950369

Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.

Jie Yin1, Kerim Babaoglu2, Chad A Brautigam1, Lindsay Clark1, Zhenhua Shao1, Thomas H Scheuermann1, Charles M Harrell3, Anthony L Gotter3, Anthony J Roecker4, Christopher J Winrow3, John J Renger3, Paul J Coleman4, Daniel M Rosenbaum1.   

Abstract

The orexin (also known as hypocretin) G protein-coupled receptors (GPCRs) regulate sleep and other behavioral functions in mammals, and are therapeutic targets for sleep and wake disorders. The human receptors hOX1R and hOX2R, which are 64% identical in sequence, have overlapping but distinct physiological functions and potential therapeutic profiles. We determined structures of hOX1R bound to the OX1R-selective antagonist SB-674042 and the dual antagonist suvorexant at 2.8-Å and 2.75-Å resolution, respectively, and used molecular modeling to illuminate mechanisms of antagonist subtype selectivity between hOX1R and hOX2R. The hOX1R structures also reveal a conserved amphipathic α-helix, in the extracellular N-terminal region, that interacts with orexin-A and is essential for high-potency neuropeptide activation at both receptors. The orexin-receptor crystal structures are valuable tools for the design and development of selective orexin-receptor antagonists and agonists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26950369     DOI: 10.1038/nsmb.3183

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  62 in total

1.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.

Authors:  Alexander Heifetz; G Benjamin Morris; Philip C Biggin; Oliver Barker; Tara Fryatt; Jonathan Bentley; David Hallett; Dominique Manikowski; Sandeep Pal; Rita Reifegerste; Mark Slack; Richard Law
Journal:  Biochemistry       Date:  2012-04-05       Impact factor: 3.162

4.  Scoring and lessons learned with the CSAR benchmark using an improved iterative knowledge-based scoring function.

Authors:  Sheng-You Huang; Xiaoqin Zou
Journal:  J Chem Inf Model       Date:  2011-08-31       Impact factor: 4.956

5.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

6.  Orexin-A, an hypothalamic peptide with analgesic properties.

Authors:  S Bingham; P T Davey; A J Babbs; E A Irving; M J Sammons; M Wyles; P Jeffrey; L Cutler; I Riba; A Johns; R A Porter; N Upton; A J Hunter; A A Parsons
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

7.  Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Authors:  Syed Sohail Ahmed; Wayne Volkmuth; José Duca; Lorenzo Corti; Michele Pallaoro; Alfredo Pezzicoli; Anette Karle; Fabio Rigat; Rino Rappuoli; Vas Narasimhan; Ilkka Julkunen; Arja Vuorela; Outi Vaarala; Hanna Nohynek; Franco Laghi Pasini; Emanuele Montomoli; Claudia Trombetta; Christopher M Adams; Jonathan Rothbard; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

8.  Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.

Authors:  Jie Yin; Juan Carlos Mobarec; Peter Kolb; Daniel M Rosenbaum
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

9.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  39 in total

1.  G protein-coupled receptors: the evolution of structural insight.

Authors:  Samantha B Gacasan; Daniel L Baker; Abby L Parrill
Journal:  AIMS Biophys       Date:  2017-08-21

Review 2.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

3.  Structure-based development of a subtype-selective orexin 1 receptor antagonist.

Authors:  Jan Hellmann; Matthäus Drabek; Jie Yin; Jakub Gunera; Theresa Pröll; Frank Kraus; Christopher J Langmead; Harald Hübner; Dorothee Weikert; Peter Kolb; Daniel M Rosenbaum; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

4.  Modeling & Informatics at Vertex Pharmaceuticals Incorporated: our philosophy for sustained impact.

Authors:  Georgia McGaughey; W Patrick Walters
Journal:  J Comput Aided Mol Des       Date:  2016-11-29       Impact factor: 3.686

Review 5.  Allosteric communication pipelines in G-protein-coupled receptors.

Authors:  Nagarajan Vaidehi; Supriyo Bhattacharya
Journal:  Curr Opin Pharmacol       Date:  2016-08-04       Impact factor: 5.547

6.  An alerting structure: human orexin receptor 1.

Authors:  Daniel Wacker; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2016-04       Impact factor: 15.369

7.  A benchmark study of loop modeling methods applied to G protein-coupled receptors.

Authors:  Lee H Wink; Daniel L Baker; Judith A Cole; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2019-05-23       Impact factor: 3.686

8.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  β2-Adrenergic Receptor Conformational Response to Fusion Protein in the Third Intracellular Loop.

Authors:  Matthew T Eddy; Tatiana Didenko; Raymond C Stevens; Kurt Wüthrich
Journal:  Structure       Date:  2016-11-10       Impact factor: 5.006

Review 10.  Therapeutics development for addiction: Orexin-1 receptor antagonists.

Authors:  David A Perrey; Yanan Zhang
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.